Pharmaceutical industry specialists from around the world highly appreciate Silvanols Ltd. products, which have been scientifically proven to be effective and safe
On 5.-7.november, the Latvian green pharmaceutical company Silvanols Ltd. participated in the world’s largest international pharmaceutical exhibition CPhI Worldwide 2020 in Frankfurt alongside Olainfarm JSC. The highlight for the second year in a row was the GoRespiro line of products, which have been scientifically proven to be effective.
The green pharmaceutical company Silvanols Ltd. met with its European partners from Poland, Greece, Romania, Ukraine and Serbia at the international exhibition CPhI Worldwide 2020 in order to discuss their collaboration so far, as well as the evolution of their product portfolio.
Both existing and potential partners were introduced to the positive results of the 2018 GoRespiro capsule (formerly Astmosil, which has now been improved) clinical effectiveness and safety observations. This generated great interest in respiratory health products from clients, especially because such observations are rarely conducted by food supplement manufacturers, and this is the first time it has been done at all with a natural preparation that has been made in Latvia.
The research Silvanols Ltd. invested in ensured further success. During the exhibition, Silvanols Ltd. signed an agreement to distribute GoRespiro in Portugal.
During the exhibition, conversations with pharmaceutical industry specialists from Morocco, Hungary and Germany showed great potential for establishing future collaboration.
In the three days of this particular exhibition, Silvanols Ltd. representatives managed to network with nearly 200 industry specialists.
Silvanols Ltd. specialists also familiarized themselves with the newest developments in raw materials and packaging by visiting other industry professional’s booths and by meeting with Silvanols Ltd. existing partners.
CPhI Worldwide is and has been the largest pharmaceutical exhibition in the world for the past 30 years. Additional information: https://www.cphi.com/europe/
